NZ shares rise as vaccine trial boosts global sentiment

NZ shares rise as vaccine trial boosts global sentiment

New Zealand shares rose for a third day as investors welcomed interim results of a covid-19 vaccine trial which showed a positive immune response to the virus.




BusinessDesk


Stories written by multiple reporters.

Followers will be emailed articles by BusinessDesk